The growth trajectory of the eye health supplements sector in China is fundamentally driven by two major, opposing demographic forces: the rising geriatric population and the high prevalence of digital screen usage among younger cohorts. The aging demographic presents a growing patient base susceptible to chronic, degenerative conditions such as Age-related Macular Degeneration (AMD) and Cataract. For these conditions, supplements focus on high-dose antioxidants (Lutein, Zeaxanthin, various vitamins) and tissue-supportive elements designed to slow disease progression and maintain residual visual function.

Conversely, the working-age and pediatric populations face modern challenges, primarily Eye Fatigue and potentially accelerated Myopia progression due to prolonged screen time. Supplements tailored to this group often emphasize compounds like Flavonoids, which are hypothesized to improve micro-circulation and blood flow to the eyes, alongside anti-inflammatory Omega-3s to alleviate strain-induced symptoms. The market is thus segmented by application to address distinct pathophysiological needs, ranging from the structural support required for Corneal Support and management of Glaucoma, to the symptomatic relief for conditions like Eyelid Conjunctivitis. This clear segmentation based on specific ocular pathologies underscores the market's response to defined epidemiological patterns, a strategy analyzed within technical documents such as the China Eye Health Supplements Market Analysis.